69 related articles for article (PubMed ID: 22993334)
1. Gene expression profiling of adult t(4;11)(q21;q23)-associated acute lymphoblastic leukemia reveals a different signature from pediatric cases.
De Braekeleer E; Douet-Guilbert N; Le Bris MJ; Basinko A; Morel F; De Braekeleer M
Anticancer Res; 2012 Sep; 32(9):3893-9. PubMed ID: 22993334
[TBL] [Abstract][Full Text] [Related]
2. The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trial.
Marks DI; Moorman AV; Chilton L; Paietta E; Enshaie A; DeWald G; Harrison CJ; Fielding AK; Foroni L; Goldstone AH; Litzow MR; Luger SM; McMillan AK; Racevskis J; Rowe JM; Tallman MS; Wiernik P; Lazarus HM
Haematologica; 2013 Jun; 98(6):945-52. PubMed ID: 23349309
[TBL] [Abstract][Full Text] [Related]
3. miR-130b and miR-128a are essential lineage-specific codrivers of t(4;11) MLL-AF4 acute leukemia.
Malouf C; Antunes ETB; O'Dwyer M; Jakobczyk H; Sahm F; Landua SL; Anderson RA; Soufi A; Halsey C; Ottersbach K
Blood; 2021 Nov; 138(21):2066-2092. PubMed ID: 34111240
[TBL] [Abstract][Full Text] [Related]
4. Development of five dual-color, double-fusion fluorescence in situ hybridization assays for the detection of common MLL translocation partners.
Keefe JG; Sukov WR; Knudson RA; Nguyen LP; Williamson C; Sinnwell JP; Ketterling RP
J Mol Diagn; 2010 Jul; 12(4):441-52. PubMed ID: 20539022
[TBL] [Abstract][Full Text] [Related]
5. Identification of genes transcriptionally responsive to the loss of MLL fusions in MLL-rearranged acute lymphoblastic leukemia.
van der Linden MH; Seslija L; Schneider P; Driessen EM; Castro PG; Stumpel DJ; van Roon E; de Boer J; Williams O; Pieters R; Stam RW
PLoS One; 2015; 10(3):e0120326. PubMed ID: 25793396
[TBL] [Abstract][Full Text] [Related]
6. A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program.
Rice S; Jackson T; Crump NT; Fordham N; Elliott N; O'Byrne S; Fanego MDML; Addy D; Crabb T; Dryden C; Inglott S; Ladon D; Wright G; Bartram J; Ancliff P; Mead AJ; Halsey C; Roberts I; Milne TA; Roy A
Nat Commun; 2021 Nov; 12(1):6905. PubMed ID: 34824279
[TBL] [Abstract][Full Text] [Related]
7. The fetal liver lymphoid-primed multipotent progenitor provides the prerequisites for the initiation of t(4;11)
Malouf C; Ottersbach K
Haematologica; 2018 Dec; 103(12):e571-e574. PubMed ID: 29903765
[No Abstract] [Full Text] [Related]
8. Genome editing-induced t(4;11) chromosomal translocations model B cell precursor acute lymphoblastic leukemias with KMT2A-AFF1 fusion.
Pan F; Sarno J; Jeong J; Yang X; Jager A; Gruber TA; Davis KL; Cleary ML
J Clin Invest; 2024 Jan; 134(1):. PubMed ID: 37917159
[TBL] [Abstract][Full Text] [Related]
9. RUNX1 is a key target in t(4;11) leukemias that contributes to gene activation through an AF4-MLL complex interaction.
Wilkinson AC; Ballabio E; Geng H; North P; Tapia M; Kerry J; Biswas D; Roeder RG; Allis CD; Melnick A; de Bruijn MF; Milne TA
Cell Rep; 2013 Jan; 3(1):116-27. PubMed ID: 23352661
[TBL] [Abstract][Full Text] [Related]
10. Activity of immunoproteasome inhibitor ONX-0914 in acute lymphoblastic leukemia expressing MLL-AF4 fusion protein.
Jenkins TW; Downey-Kopyscinski SL; Fields JL; Rahme GJ; Colley WC; Israel MA; Maksimenko AV; Fiering SN; Kisselev AF
Sci Rep; 2021 May; 11(1):10883. PubMed ID: 34035431
[TBL] [Abstract][Full Text] [Related]
11. Enhanced hemato-endothelial specification during human embryonic differentiation through developmental cooperation between
Bueno C; Calero-Nieto FJ; Wang X; Valdés-Mas R; Gutiérrez-Agüera F; Roca-Ho H; Ayllon V; Real PJ; Arambilet D; Espinosa L; Torres-Ruiz R; Agraz-Doblas A; Varela I; de Boer J; Bigas A; Gottgens B; Marschalek R; Menendez P
Haematologica; 2019 Jun; 104(6):1189-1201. PubMed ID: 30679325
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study.
Moorman AV; Barretta E; Butler ER; Ward EJ; Twentyman K; Kirkwood AA; Enshaei A; Schwab C; Creasey T; Leongamornlert D; Papaemmanuil E; Patrick P; Clifton-Hadley L; Patel B; Menne T; McMillan AK; Harrison CJ; Rowntree CJ; Marks DI; Fielding AK
Leukemia; 2022 Mar; 36(3):625-636. PubMed ID: 34657128
[TBL] [Abstract][Full Text] [Related]
13. Functional relevance of circRNA aberrant expression in pediatric acute leukemia with KMT2A::AFF1 fusion.
Tretti Parenzan C; Molin AD; Longo G; Gaffo E; Buratin A; Cani A; Boldrin E; Serafin V; Guglielmelli P; Vannucchi AM; Cazzaniga G; Biondi A; Locatelli F; Meyer LH; Buldini B; Te Kronnie G; Bresolin S; Bortoluzzi S
Blood Adv; 2024 Mar; 8(5):1305-1319. PubMed ID: 38029383
[TBL] [Abstract][Full Text] [Related]
14. HOXA9/IRX1 expression pattern defines two subgroups of infant MLL-AF4-driven acute lymphoblastic leukemia.
Symeonidou V; Ottersbach K
Exp Hematol; 2021 Jan; 93():38-43.e5. PubMed ID: 33069783
[TBL] [Abstract][Full Text] [Related]
15. Hypothalamic obesity syndrome: rare presentation of CNS+ B-cell lymphoblastic lymphoma.
Quigg TC; Haddad NG; Buchsbaum JC; Shih CS
Pediatr Blood Cancer; 2012 Nov; 59(5):930-3. PubMed ID: 22213612
[TBL] [Abstract][Full Text] [Related]
16. A human genome editing-based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features.
Bueno C; Torres-Ruiz R; Velasco-Hernandez T; Molina O; Petazzi P; Martinez A; Rodriguez V; Vinyoles M; Cantilena S; Williams O; Vega-Garcia N; Rodriguez-Perales S; Segovia JC; Quintana-Bustamante O; Roy A; Meyer C; Marschalek R; Smith AL; Milne TA; Fraga MF; Tejedor JR; Menéndez P
Blood; 2023 Nov; 142(20):1752-1756. PubMed ID: 37756522
[TBL] [Abstract][Full Text] [Related]
17. B-cell acute lymphoblastic leukemia with t(4;11)(q21;q23) in a young woman: evolution into mixed phenotype acute leukemia with additional chromosomal aberrations in the course of therapy.
Carulli G; Marini A; Ferreri MI; Azzarà A; Ottaviano V; Lari T; Rocco M; Giuntini S; Petrini M
Hematol Rep; 2012 Jul; 4(3):e15. PubMed ID: 23087804
[TBL] [Abstract][Full Text] [Related]
18. MLL-AF4, a double-edged sword for iPSC respecification into HSPCs.
Zeisig BB; So CWE
Proc Natl Acad Sci U S A; 2018 Feb; 115(9):1964-1966. PubMed ID: 29444865
[No Abstract] [Full Text] [Related]
19. MLL leukemia-associated rearrangements in peripheral blood lymphocytes from healthy individuals.
Brassesco MS; Montaldi AP; Gras DE; de Paula Queiroz RG; Martinez-Rossi NM; Tone LG; Sakamoto-Hojo ET
Genet Mol Biol; 2009 Apr; 32(2):234-41. PubMed ID: 21637673
[TBL] [Abstract][Full Text] [Related]
20. Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteins.
Steimlé T; Dourthe ME; Alcantara M; Touzart A; Simonin M; Mondesir J; Lhermitte L; Bond J; Graux C; Grardel N; Cayuela JM; Arnoux I; Gandemer V; Balsat M; Vey N; Macintyre E; Ifrah N; Dombret H; Petit A; Baruchel A; Ruminy P; Boissel N; Asnafi V
Blood Cancer J; 2022 Jan; 12(1):14. PubMed ID: 35082269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
